Sort
51,593 grants matching “hepatitis”
Health Literacy Assessment and Intervention to Reduce Disparities: FLIGHT/VIDAS II
$569,078Raymond L Ownby · Nova Southeastern University · R56 · FY2015 · HL
Functions of vitamin E and the tocopherol transfer protein
$569,059Danny Manor · Case Western Reserve University · R01 · FY2024 · DK
Mechanistic function of HCV NS5A targeted by the potent inhibitors
$569,025Minkyung Yi · University Of Texas Med Br Galveston · R01 · FY2020 · AI
The Environment as a Variable to Calibrate Mouse Models of Human Disease
$568,985John M Essigmann · Massachusetts Institute Of Technology · R01 · FY2010 · ES
Anchimerically Activatable Anti-Zika/Dengue ProTides
$568,956Carston R. Wagner · University Of Minnesota · R01 · FY2024 · AI
Anchimerically Activatable Anti-Zika/Dengue ProTides
$568,956Carston R. Wagner · University Of Minnesota · R01 · FY2022 · AI
Anchimerically Activatable Anti-Zika/Dengue ProTides
$568,956Carston R. Wagner · University Of Minnesota · R01 · FY2025 · AI
Anchimerically Activatable Anti-Zika/Dengue ProTides
$568,956Carston R. Wagner · University Of Minnesota · R01 · FY2023 · AI
Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs
$568,934Richard S Garfein · University Of California, San Diego · R01 · FY2015 · DA
Determinants of Liver Injury in Chronic Hepatitis C Virus Infection
$568,906Margaret J Koziel · Beth Israel Deaconess Medical Center · U19 · FY2007 · AI
Significance and mechanisms of hepatic ChREBPα induction via post-translational modifications in diet-induced NASH
$568,905Lei Yin · University Of Michigan At Ann Arbor · R01 · FY2025 · DK
Technical Validation of MRI Biomarkers of Liver Fat
$568,774Claude B Sirlin · University Of California, San Diego · R01 · FY2014 · DK
HCV Replication and Immune Response in HIV Coinfection
$568,768David Richard Gretch · University Of Washington · R01 · FY2007 · AI
Identifying and modulating therapeutic targets in a model of hepatitis B
$568,736Jody L Baron · University Of California, San Francisco · R01 · FY2019 · AI
Taking aim at HBV eradication using novel NRTIs and Capsid effectors
$568,676Stefan G Sarafianos · Emory University · R01 · FY2020 · AI
Small Molecule Inhibitors Targeting Adenovirus
$568,581Charles E McKenna · University Of Southern California · R01 · FY2023 · AI
Psychoeducation for HCV and Alcohol Behaviors
$568,558Carol S North · Ut Southwestern Medical Center · R01 · FY2010 · AA
Therapeutic Approaches to Dysregulated HDL Metabolism
$568,539Henry J. Pownall · Baylor College Of Medicine · R01 · FY2010 · HL
ALTERATIONS OF NEUROENDOCRINE STRESS RESPONSIVITY IN SPECIFIC ADDICTIVE DISEAS...
$568,535Mary J Kreek · Rockefeller University · P60 · FY2010 · DA
Pathogenesis of Liver Disease in Hepatitis
$568,508Francis Vincent Chisari · Scripps Research Institute, The · R01 · FY2007 · AI
Hepatic stellate cell plasticity and maladaptive fibrogenic memory in chronic liver disease
$568,494Shuang Wang · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DK
HCV Replication and Immune Response in HIV Coinfection
$568,445David Richard Gretch · University Of Washington · R01 · FY2008 · AI
Carbohydrate-Mediated Platelet Clearance
$568,324Karin Maria Hoffmeister · Versiti Wisconsin, Inc. · R01 · FY2024 · HL
Impaired VLDL secretion in progression of NAFLD and NASH in mice and humans
$568,310Nicholas Davidson · Washington University · R01 · FY2024 · DK
Restoring awareness of hypoglycemia in type 1 diabetes
$568,303Michael R Rickels · University Of Pennsylvania · U01 · FY2025 · DK